Visualization of Intermetastatic Heterogeneity in Mixed Neuroendocrine Carcinoma-Acinar Adenocarcinoma of the Prostate by 68Ga-PSMA, 68Ga-FAPI, and 18F-FDG PET/CT

被引：4

作者：

Cai, Jiayu ^{[1
,2
]}

Xu, Weizhi ^{[1
,2
]}

Meng, Tinghua ^{[1
,2
]}

Pang, YiZhen ^{[1
,2
]}

Chen, Haojun ^{[1
,2
,3
]}

机构：

[1] Xiamen Univ, Affiliated Hosp 1, Xiamen Canc Ctr, Sch Med,Dept Nucl Med, Xiamen, Peoples R China

[2] Xiamen Univ, Affiliated Hosp 1, Minnan PET Ctr, Xiamen Canc Ctr,Sch Med, Xiamen, Peoples R China

[3] 55 Zhenhai Rd, Xiamen 361003, Peoples R China

来源：

CLINICAL NUCLEAR MEDICINE | 2023年 / 48卷 / 08期

基金：

中国国家自然科学基金;

关键词：

F-18-FDG; Ga-68-FAPI; Ga-68-PSMA; neuroendocrine adenocarcinoma; neuroendocrine prostate cancer; PET/CT;

D O I：

10.1097/RLU.0000000000004719

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Mixed neuroendocrine carcinoma-acinar carcinoma is an uncommon histological type of neuroendocrine prostate cancer. It has been rarely reported in de novo prostate malignancies. In this case, we present Ga-68-PSMA (prostate-specific membrane antigen), Ga-68-FAPI, and F-18-FDG PET/CT findings in the de novo form of mixed large-cell neuroendocrine carcinoma-acinar adenocarcinoma of the prostate. Different levels of radiotracer uptake were observed in different metastatic sites on Ga-68-PSMA, Ga-68-FAPI, and F-18-FDG PET/CT. This case demonstrates that the multitracer PET/CT strategy may be used for the noninvasive detection of the intermetastatic heterogeneity in metastatic neuroendocrine prostate cancer.

引用

页码：743 / 745

页数：3

共 50 条

[31] Comparison of 68Ga-FAPI versus 18F-FDG PET/CT for Initial Cancer Staging
Taveira, Mateus
RADIOLOGY-IMAGING CANCER, 2021, 3 (02):
[32] 68Ga-FAPI outperforms 18F-FDG PET/CT in identifying solitary fibrous tumor
Rongxi Wang
Qingxing Liu
Huimin Sui
Mu Zhang
Zhaohui Zhu
Ruixue Cui
European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2055 - 2056
[33] 68Ga-PSMA PET/CT and 18F-FDG PET/CT in the diagnosis of prostatic ductal cancer
Huang, Haijun
Zou, Sijuan
Wan, Jie
Zeng, Xing
Wang, Shaogang
Hu, Zhiquan
Zhu, Xiaohua
Yang, Chunguang
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (12) : 448E9 - 448E16
[34] Can 68Ga-FAPI PET/CT Replace 18F-FDG PET/CT in Breast Cancer Staging?
Alcin, G.
Arslan, E.
Aksoy, T.
Fenercioglu, O. Erol
Beyhan, E.
Ergul, N.
Cermik, T. F.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S378 - S378
[35] Intraindividual comparison of 68Ga-FAPI PET/CT with 18F-FDG PET/CT for imaging of cancer of the cervix
Mokoala, Kgomotso
Maserumule, Letjie
Mokgoro, Neo
Ndlovu, Honest
Ismaila, Aisha
Ebenhan, Thomas
Zeevaart, Jan Rijn
Sathekge, Mike
JOURNAL OF NUCLEAR MEDICINE, 2024, 65
[36] Pulmonary Cryptococcosis: Intense Uptake on Both 18F-FDG and 68Ga-FAPI PET/CT
Liu, Mengna
Liu, Huipan
Chen, Xi
Zhang, Song
Cai, Liang
CLINICAL NUCLEAR MEDICINE, 2023, 48 (11) : 980 - 981
[37] Presacral Benign Schwannoma Mimics Malignancy on 18F-FDG and 68Ga-FAPI PET/CT
Zhu, Yahua
Wu, Junhao
Wang, Yingwei
Geng, Jun
Zhang, Chunyin
CLINICAL NUCLEAR MEDICINE, 2022, 47 (03) : 277 - 278
[38] Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Advanced Lung Cancer
Wang, Lijuan
Tang, Ganghua
Hu, Kongzhen
Liu, Xinran
Zhou, Wenlan
Li, Hongsheng
Huang, Shun
Han, Yanjiang
Chen, Li
Zhong, Jinmei
Wu, Hubing
RADIOLOGY, 2022, 303 (01) : 191 - 199
[39] False-Negative 68Ga-FAPI PET/CT in Pediatric Thyroid Medullary Carcinoma Seen With 68Ga-DOTATOC PET/CT and 18F-FDG PET/CT
Haidar, Mohamad B.
Abou Zeid, Farah A.
Meguerian, Zarouhie Z.
Al-Ibraheem, Akram N.
Noun, Peter E.
CLINICAL NUCLEAR MEDICINE, 2024, 49 (07) : 690 - 692
[40] Evaluation of 68Ga-FAPI PET/CT and 18F-FDG PET/CT for the diagnosis of recurrent colorectal cancers
Xi, Yue
Sun, Yuyun
Gu, Bingxin
Bian, Linjie
Song, Shaoli
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 49

← 1 2 3 4 5 →